pennystocksupdate.biz issues special report on current market situation - Patriot Coal Corporation (OTCMKTS:PCXCQ), Novation Companies Inc (OTCMKTS:NOVC), American Oriental Bioengineering, Inc. (OTCMKTS:AOBI), Pharmagen Inc (OTCMKTS:PHRX), Marina Biotech, Inc. (OTCMKTS:MRNA)
New York, NY -- (SBWIRE) -- 10/29/2013 -- Patriot Coal Corporation (OTCMKTS:PCXCQ) is -0.02 - -16.67% from the previous close of $0.12. It traded between $0.10 - 0.1195 with total traded volume of 1476024 shares. At Current Market Price, PCXCQ is in distance of -52.32% from its 50-day Moving Average price of $0.2097 and -37.05% from its 200-day Moving Average price of $0.1589. Patriot Coal Corporation is a producer of thermal coal in the eastern United States, with operations and coal reserves in the Appalachia and the Illinois Basin coal regions. The Company operates in two segments: Appalachia Mining Operations and Illinois Basin Mining Operations. Patriot is also a United States producer of metallurgical quality coal. Its principal business is the mining and preparation of thermal coal or steam coal, for sale primarily to electricity generators, and metallurgical coal, for sale to steel mills and independent coke producers.
How Should Investors Trade PCXCQ After The Recent Volatile Moves? Find Out Here
Novation Companies Inc (OTCMKTS:NOVC) is -0.022 - -5.95% from the previous close of $0.37. It traded between $0.325 - 0.348 with total traded volume of 7125 shares. Keep a close eye on NOVC, as the stock has been showing unusual moves over the past weeks. At Current market price, NOVC has recovered -0.57% from its 52-week Low of 0.35 and has Pulled back -46.46% from its 52-week high of 0.65. Novation Companies, Inc. (Novation) is engaged in the business strategy of acquiring and operating technology-enabled service businesses. The Company operates in four segments: Corporate, Appraisal Management, Financial Intermediary, and Logistics. Corporate operating results include mortgage securities retained from securitizations, corporate general and administrative expenses, and the operating results of Cloud. Appraisal Management operations include the service fee income and related expenses from the Company's majority-owned subsidiary, StreetLinks.
Can NOVC Bounce Back? Find Out Here
American Oriental Bioengineering, Inc. (OTCMKTS:AOBI) is traded between $0.32 - 0.36 with total traded volume of 3200 shares. At a current price of 0.35, AOBI is -0.086 - -19.72% from the previous close of $0.436. Moreover, At Current Market Price, AOBI is in distance of -33.02% from its 50-day Moving Average price of $0.5226 and -30.95% from its 200-day Moving Average price of $0.5069. American Oriental Bioengineering, Inc. is an integrated pharmaceutical company. The Company is engaged in development, manufacture and commercialization of a broad range of pharmaceutical and healthcare products. The Company’s products are manufactured using plant based materials. The Company’s business is consists of prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products. . The Company’s pharmaceutical products were approved by the Chinese State Food and Drug Administration (SFDA).
Can AOBI Recover After The Recent Fall? Find Out Here
Shares of Pharmagen Inc (OTCMKTS:PHRX) are trading at $0.0075 and is -63.03% from its 50-day Moving Average price of $0.0203 and -73.21% from its 200-day Moving Average price of $0.028. The average trading volume is 398600 shares and its market capitalization is $2.9M. Pharmagen, Inc., formerly Sunpeaks Ventures, Inc is a dynamic distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter (OTC) branded multivitamins to the healthcare provider market. The Company functions as a total solution provider to hospitals through sterile compounding/admix pharmacy and just-in-time source of supply of products that are hard-to-find due to drug manufacturers’ production shortages. The Company’s operations are conducted through its wholly-owned subsidiaries, Pharmagen Distribution, LLC, or PDS (formerly known as Health Distribution Specialists, LLC), and Pharmagen Laboratories, Inc. (formerly known as Bryce Rx Laboratories, Inc.).
Should Investors Buy PHRX After The Recent Drop? Find Out Here
Marina Biotech, Inc. (OTCMKTS:MRNA) is -0.009 - -3.60% from the previous close of $0.25. It traded between $0.241 - 0.241 with total traded volume of 275 shares. Keep a close eye on MRNA, as the stock has been showing unusual moves over the past weeks. At Current market price, MRNA has recovered +33.89% from its 52-week Low of 0.18 and has Pulled back -65.57% from its 52-week high of 0.70. At Current Market Price, MRNA is in distance of -6.59% from its 50-day Moving Average price of $0.258 and -8.09% from its 200-day Moving Average price of $0.2622. Marina Biotech, Inc. is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies utilizing gene silencing approaches such as RNA interference (RNAi) and blocking messenger RNA (mRNA) translation. The Company's pipeline includes a clinical program in Familial Adenomatous Polyposis (FAP) and preclinical programs in bladder cancer and myotonic dystrophy.
Should Investors Buy MRNA After The Recent Drop? Find Out Here
Neither Pennystocksupdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Adviser or broker dealer in any jurisdiction whatsoever and none of the information provided by Pennystocksupdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. Pennystocksupdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Pennystocksupdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Read Full disclaimer at: http://pennystocksupdate.biz/offer/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)